Neurological Disorders and Chronic Pain
Date/Time: Sunday, July 21, 2019 - 3:30 PM to 5:30 PM
Log in to Add to My Schedule
We are living longer, so the prevalence of aging-related diseases is exponentially growing. Neurological disorders (epilepsy, Parkinson’s disease; Alzheimer’s disease, etc.) as well as chronic pain are two of the most prevalent diseases of the aging population. The economic cost to society is staggering, estimated around $560–635 billion annually in the US alone for direct medical treatment costs and lost productivity. In the case of chronic pain, additional complications may include over-prescriptions and addictions. Drug delivery technologies and nanomedicine offers unprecedented opportunities in the development of novel pain assessment, diagnostic, and therapeutic delivery mechanisms that will address many of the global unmet needs in pain and neurological disorders management. Specially-designed nanocarriers able to cross the blood brain barrier (BBB) to deliver their payload at pre-defined location(s) according to specified time- and dose-fractionations while remaining unnoticed by the immune system will soon make a difference in the treatment and early diagnostics of neurological disorders.